Supernus Pharmaceuticals (SUPN) Change in Intangibles (2016 - 2021)
Supernus Pharmaceuticals has reported Change in Intangibles over the past 9 years, most recently at $453000.0 for Q1 2021.
- Quarterly Change in Intangibles changed N/A to $453000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $594000.0 through Mar 2021, down 55.93% year-over-year, with the annual reading at $1.3 million for FY2019, 66.75% up from the prior year.
- Change in Intangibles was $453000.0 for Q1 2021 at Supernus Pharmaceuticals, up from $117000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $5.8 million in Q2 2017 and troughed at $1000.0 in Q1 2019.
- The 5-year median for Change in Intangibles is $343000.0 (2018), against an average of $1.1 million.
- The largest YoY upside for Change in Intangibles was 936.92% in 2019 against a maximum downside of 99.71% in 2019.
- A 5-year view of Change in Intangibles shows it stood at $1.0 million in 2017, then plummeted by 87.3% to $130000.0 in 2018, then surged by 936.92% to $1.3 million in 2019, then plummeted by 91.32% to $117000.0 in 2020, then soared by 287.18% to $453000.0 in 2021.
- Per Business Quant, the three most recent readings for SUPN's Change in Intangibles are $453000.0 (Q1 2021), $117000.0 (Q3 2020), and $24000.0 (Q2 2020).